{
  "id": 792951,
  "title": "Ovid and Takeda's epilepsy drug gets new life at Perceptive-backed NewCo",
  "url": "https://urgent.news/2026/08/13/ovid-and-takedas-epilepsy-drug-gets-new-life-at-perceptive-backed",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-13T18:31:07.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/ovid-and-takedas-epilepsy-drug-gets-new-life-at-perceptive-backed-newco/"
  },
  "original_language": "en",
  "account": null,
  "summary": "About 26 months after failing two Phase 3 trials, an epilepsy treatment candidate is getting plucked off biopharma's shelves and will be given a new chance at life. Life sciences investment firm Perceptive Advisors is ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}